Annual report [Section 13 and 15(d), not S-K Item 405]

Revenue

v3.25.4
Revenue
 12 Months Ended
Dec. 31, 2025
Revenue Recognition [Abstract]  
Revenue Revenue
Disaggregated Revenue
The following table presents the Company’s disaggregated revenue by offering type (in thousands):
Years Ended December 31,
2025 2024
Total Net
Revenues
% of
Total Net
Revenues
Total Net
Revenues
% of
Total Net
Revenues
Patient Services revenue recognized at a point in time:
Direct products
 $ 2,591  1.8  % $ 2,706  2.0  %
Third-Party Payer products
 17,750  12.4  % 15,023  11.1  %
Patient Services revenue recognized over time:
Direct rental services
 7,755  5.4  % 7,683  5.7  %
Third-Party Payer rental services
 50,091  34.9  % 47,394  35.1  %
Total Patient Services accounted for under ASC 606
 78,187  54.5  % 72,806  53.9  %
Device Solutions revenue recognized at a point in time:
Products
 17,274  12.0  % 16,552  12.3  %
Services
 11,829  8.2  % 8,861  6.6  %
Device Solutions revenue recognized over time:
Services 5,790  4.0  % 8,082  6.0  %
Total Device Solutions accounted for under ASC 606
 34,893  24.3  % 33,495  24.9  %
Total Revenue Accounted for under ASC 606
 113,080  78.8  % 106,301  78.8  %
Patient Services Lease Revenue
 8,345  5.8  % 7,572  5.6  %
Device Solutions Lease Revenue
 22,011  15.3  % 20,988  15.6  %
Total Revenue accounted for under ASC 842
 30,356  21.2  % 28,560  21.2  %
Total Net Revenue
 $ 143,436  100.0  % $ 134,861  100.0  %
Contract Balances
2025 2024
Change in 2025
Accounts receivable, net $ 22,901  $ 21,155  $ 1,746 
Contract assets $ 1,244  $ 570  $ 674 
Contract liabilities $ 109  $ —  $ 109 

The change in contract assets during the fiscal year ended December 31, 2025 was mainly due to $8.7 million of contract assets reclassified to accounts receivable as our right to consideration for these contract assets became unconditional, partially offset by $9.4 million of revenue recognized for which the payment is subject to conditions other than the passage of time. Contract assets are included in other current assets on the Company's consolidated balance sheets.